Search and Find the CMO / CDMO You Need
Discover highly skilled partners for your drug development and manufacturing project.
Belgium
Cenexi Laboratoires Thissen
Cenexi
This 8,000 m2 plant, with buildings dotted around a site of nearly seven hectares, is located 20 km south of Brussels and has 340 employees*.
OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
BSL (Biological Safety Level): 3, 4, 1, 2
CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)
REGION: Europe
COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
BATCH SIZE: Large, Small, Medium
USE: Human, Veterinary
SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
THERAPEUTIC AREAS OF EXPERTISE (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (G) Genito urinary system and sex hormones
CATEGORY / PRODUCT: FDF / DRUG PRODUCTS
Limited view
CHEMICAL-SYNTHETIC manufacturing site
MAI network supplier
Solutions for non Viral Delivery programs
Location available after registration
Limited view
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
A GMP facility fully equipped for R&D and pharmaceutical development. Includes laboratories and a pilot plant for technical and clinical batches.
Location available after registration
Limited view
OLIGONUCLEOTIDES manufacturing site
MAI network supplier
Development and manufacturing of oral solid dose (OSD), nasal, inhalation, and sterile dry powders and liquids drug products.
Location available after registration
Suggested Results
These facilities match your main criteria but not all optional filters.
Limited view
SERVICES manufacturing site
MAI network supplier
Lyo CDMO
Location available after registration
Limited view
OLIGONUCLEOTIDES manufacturing site
MAI network supplier
Polpharma API is part of Poland's leading multinational pharmaceutical group, with more than 90 years of experience serving patients and business partners worldwide. As a CDMO specializing in small…
Location available after registration
Limited view
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
Biopharma Contract Packaging
Location available after registration
Belgium
White Raven - Legiapark
White Raven
Fill and finish site dedicated to GMP Formulation and the Aseptic filling of Sterile Liquid Injectables.
OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
MARKETS: EMA (EU)
REGION: Europe
USE: Human
BSL (Biological Safety Level): 1, 2
SERVICES: Manufacturing services, Packaging
BATCH SIZE: Small, Medium
COMPLIANCE: EMA (EU GMP)
CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS
Limited view
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
CDMO Sterile Oncology Drugs.
Location available after registration
Limited view
SERVICES manufacturing site
MAI network supplier
Make affordable healthcare solutions that improve and simplify patients lives.
Location available after registration